Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Suzanne Turner. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Suzanne Turner or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Season 2, Episode 6: Biotech, Business, and Brandon: A Conversation with Amin Jagani

48:38
 
Share
 

Manage episode 505160163 series 3584358
Content provided by Suzanne Turner. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Suzanne Turner or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Send us a text


Biotech, Business, and Brandon: A Conversation with Amin Jagani

Show Description & Notes

What do a licensed pharmacist, biotech entrepreneur, clinical site founder, and professor all have in common? This guy.

In this energizing conversation, Suzanne sits down with pharmaceutical leader Amin Jagani to talk about his 25-year journey across nearly every corner of the drug development world—from CRA to biotech founder to venture advisor. They explore what’s changing (hello, AI and decentralized trials), what’s holding us back (yes, we’re still struggling with patient recruitment), and the real-life moments that keep us going—like Brandon, a patient whose story became Amin’s driving force.

We dig into:

  • The evolution of CRA roles and trial models
  • How mergers, acquisitions, and patent cliffs are shaping biotech
  • What every professional should understand about trial efficiency
  • Why understanding business is just as important as science
  • A preview of what the next decade may hold for clinical research

📘 About the Guest

Amin Jagani is a seasoned pharmaceutical leader with over 20 years of experience in drug development, holding key roles at Procter & Gamble, Eli Lilly, and global contract research organizations like Parexel, PPD, and Syneos. As a serial entrepreneur, he has founded three biotech ventures, achieving two successful exits.

He authored The Profit Pill, a book on biotech investing, and has served as an advisor, board member, and editor for industry publications. Amin holds degrees in Cell & Molecular Biology, Pharmacy, and an MBA in Corporate Finance and Entrepreneurship. He has pursued advanced studies at Harvard Medical School and the Ivey School of Business.


Beyond work, he is a licensed pharmacist, adjunct professor, and a dedicated martial artist and competitive tennis player.

📍 Connect with Amin Jagani

Website: hyggroupinc.com

Email: [email protected]

The Profit Pill: The Profit Pill: How to make make money in the pharmaceutical industry: Jagani, Amin, Jagani, Amin: 9781777513610: Amazon.com: Books

📞 Connect with Suzanne:

💌 Feedback and Questions:

🎙️ Tune in and get to know the passionate professional behind Heart of the Trial!

  continue reading

15 episodes

Artwork
iconShare
 
Manage episode 505160163 series 3584358
Content provided by Suzanne Turner. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Suzanne Turner or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Send us a text


Biotech, Business, and Brandon: A Conversation with Amin Jagani

Show Description & Notes

What do a licensed pharmacist, biotech entrepreneur, clinical site founder, and professor all have in common? This guy.

In this energizing conversation, Suzanne sits down with pharmaceutical leader Amin Jagani to talk about his 25-year journey across nearly every corner of the drug development world—from CRA to biotech founder to venture advisor. They explore what’s changing (hello, AI and decentralized trials), what’s holding us back (yes, we’re still struggling with patient recruitment), and the real-life moments that keep us going—like Brandon, a patient whose story became Amin’s driving force.

We dig into:

  • The evolution of CRA roles and trial models
  • How mergers, acquisitions, and patent cliffs are shaping biotech
  • What every professional should understand about trial efficiency
  • Why understanding business is just as important as science
  • A preview of what the next decade may hold for clinical research

📘 About the Guest

Amin Jagani is a seasoned pharmaceutical leader with over 20 years of experience in drug development, holding key roles at Procter & Gamble, Eli Lilly, and global contract research organizations like Parexel, PPD, and Syneos. As a serial entrepreneur, he has founded three biotech ventures, achieving two successful exits.

He authored The Profit Pill, a book on biotech investing, and has served as an advisor, board member, and editor for industry publications. Amin holds degrees in Cell & Molecular Biology, Pharmacy, and an MBA in Corporate Finance and Entrepreneurship. He has pursued advanced studies at Harvard Medical School and the Ivey School of Business.


Beyond work, he is a licensed pharmacist, adjunct professor, and a dedicated martial artist and competitive tennis player.

📍 Connect with Amin Jagani

Website: hyggroupinc.com

Email: [email protected]

The Profit Pill: The Profit Pill: How to make make money in the pharmaceutical industry: Jagani, Amin, Jagani, Amin: 9781777513610: Amazon.com: Books

📞 Connect with Suzanne:

💌 Feedback and Questions:

🎙️ Tune in and get to know the passionate professional behind Heart of the Trial!

  continue reading

15 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play